Mark G. Edwards, Director at ACELRX PHARMACEUTICALS INC (ACRX), bought 38,000 shares at $2.99 ($114K) on 2019-03-12, disclosed to the SEC on 2019-03-12.
Open-market purchase of $114k ACRX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.99 | 19,000 | $57K | 50.0% |
| 2 | $2.99 | 19,000 | $57K | 50.0% |
| Total | $2.99 avg | 38,000 | $114K | 100% |
| Filing → |
| ACRX | BUY | 2018-11-15 | $58K | — | Filing → |
| ACRX | BUY | 2018-08-08 | $15K | — | Filing → |
| ACRX | BUY | 2018-06-05 | $17K | — | Filing → |